Rayan Al Jurdi
Psychiatry · Houston, TXNPI 1588674691
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $269,855 of the $358,714 with a category attached, or 75.2%. Johnson & Johnson accounts for 98.3% of it on its own, with 11 other manufacturers making up the rest. Among psychiatry clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 548 payments — averaging $654.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$353K
- Janssen Scientific Affairs, LLC$3K
- Janssen Global Services, LLC$2K
- Otsuka America Pharmaceutical, Inc.$237
- AbbVie$147
- Takeda Pharmaceuticals U.S.A., Inc.$138
- plus $371 from 6 others
Across 56 payments — averaging $6301.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$353K
What the payments were for
- Consulting fees$22,8066%
- Speaking & faculty fees$269,85575%
- Travel & lodging$56,31716%
- Food & beverage$9,6643%
- Education$720%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 511 | $352,666 |
| Janssen Scientific Affairs, LLC | 3 | $3,135 |
| Janssen Global Services, LLC | 1 | $2,020 |
| Otsuka America Pharmaceutical, Inc. | 6 | $237 |
| AbbVie | 7 | $147 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $138 |
| Axsome Therapeutics, Inc. | 1 | $104 |
| Shire North American Group Inc | 4 | $89 |
| Bausch Health US, LLC | 4 | $81 |
| Neurocrine Biosciences, Inc. | 1 | $51 |
| OWP Pharmaceuticals, Inc. | 1 | $28 |
| Lundbeck LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$358,714 in reported general payments places this provider in the 95th percentile of 2,238 psychiatry providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lamotrigine ErLamotrigine | 15 | $1,612 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 19 | $1,155 |
| Vilazodone Hcl | 11 | $1,100 |
| Trazodone Hcl | 25 | $811 |
| Bupropion XlBupropion Hcl | 22 | $779 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 23 | $709 |
| Duloxetine Hcl | 17 | $379 |
| Escitalopram Oxalate | 19 | $310 |
| Gabapentin | 17 | $240 |
| Lorazepam | 14 | $225 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 14 | $204 |
| Zolpidem Tartrate | 26 | $183 |
| Sertraline Hcl | 12 | $174 |
| Mirtazapine | 17 | $173 |
| Clonazepam | 17 | $66 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Houston
- Matthew BramsHouston$1.5M
- Frank ChenHouston$941K
- Alice MaoHouston$850K
- Mazhar KhowajaHouston$843K
- Barry GritzHouston$792K
- Aaron PetersonHouston$700K
- Ayesha RashidHouston$641K
- Lawrence GinsbergHouston$502K
- Kathy FlanaganHouston$443K
- Prashant GajwaniHouston$355K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.